$ARQ

Arq, Inc. (ARQ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Arq, Inc. (ARQ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.3 4 ex103-grantnoticerestricte.htm EX-10.3 Document EXHIBIT 10.3 ARQ, INC. 2026 OMNIBUS INCENTIVE PLAN GRANT NOTICE FOR RESTRICTED STOCK UNIT AWARD FOR GOOD AND VALUABLE CONSIDERATION, Arq, Inc. (the “ Company ”), hereby grants to Participant named below the number of Restr

Original reporting
Published Jul 23, 2026, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ARQ
Neutral
medium confidence
Mentioned
$ARQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARQNeutralLow
01

Why it matters

The newest concrete information is the specific RSU grant terms: 600,000 RSUs, three VWAP tranches, change-in-control full vesting, and full vesting upon certain termination scenarios, plus stock price target adjustment if dilution exceeds 5% (with exclusions).

02

Market read

Traders may monitor whether the VWAP hurdles imply management expects the stock to trade at or above those levels, but there is no new guidance, deal, or operational update.

03

What to watch

Tranche targets ($3/$6/$9) and the change-in-control and termination acceleration could matter for longer-dated positioning around corporate events, but the filing does not announce any such event.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-07-23, for next-session positioning

Background

The 8-K Item 5.02 includes an RSU grant notice under Arq’s 2026 Omnibus Incentive Plan, with VWAP-based vesting tranches and acceleration/forfeiture provisions.

Company-level read

Ticker impact

$ARQNeutralMedium confidence
Context

Arq, Inc. granted 600,000 RSUs to Robert E. Rasmus with VWAP-based tranches at $3, $6, and $9, plus change-in-control acceleration.

Expected impact

Likely limited immediate price impact; any reaction would be sentiment-driven around executive compensation structure rather than earnings or guidance.

Evidence & confidence

This is an SEC 8-K Item 5.02 compensation grant notice. It provides specific vesting thresholds and acceleration/forfeiture terms, but no new operating, financial, or strategic information.

Market effects

No clear sector read-across; this is company-specific compensation documentation.

None indicated.

None indicated.

Counterpoint

Because vesting is tied to VWAP levels, the market may view the targets as either achievable upside alignment or as evidence of prior underperformance expectations, but the filing alone is unlikely to move the stock materially.

Key entities

  • Arq, Inc.

    Subject of the SEC 8-K and RSU grant notice under its 2026 Omnibus Incentive Plan.

  • Robert E. Rasmus

    Participant receiving 600,000 RSUs, with VWAP-based vesting and acceleration/forfeiture terms.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.